Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults with resectable locally advanced head and neck squamous cell carcinoma with PD-L1 CPS of at least 1 on an FDA-approved test. Pembrolizumab is given before surgery, with adjuvant radiotherapy with or without cisplatin, then alone.
LAMPGEN ANALYSIS
Why it matters
The approval established a perioperative PD-1 regimen in PD-L1-positive, resectable locally advanced head and neck cancer.
What research teams should watch
Arrange PD-L1 testing before surgery and protect the handoff between surgery, radiation, and systemic treatment.
PRIMARY RECORDS